Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The goal of this clinical trial is to assess the effectiveness of GS010, a gene therapy, in improving the visual outcome in participants with Leber Hereditary Optic Neuropathy (LHON) due to the G11778A ND4 mitochondrial mutation when vision loss is present for six months or less.
Epistemonikos ID: 6e40d8b40aea7b3ffd0221dafecc76620431065d
First added on: May 12, 2024